Clinical trial NCT06023836: Myofascial Pain Syndrome and Plantar Fasciitis Treatment
Official title: Myofascial Pain Syndrome in Plantar Fasciitis; Comparison of Dry Needling and Extracorporeal Shockwave Therapy (ESWT) Effects on Pain and Function
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Plantar Fascitis
Myofascial Pain Syndrome
Keywords: plantar fasciitis
ESWT
dry needling
Lead sponsor: Istanbul Training and Research Hospital
Sponsor class: OTHER_GOV
First posted: 2023-09-05
Enrollment: 66
Sex: ALL
Minimum age (years): 25
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Participants will be randomly divided into 2 groups and will be treated with ESWT or Dry needling.
Primary purpose: TREATMENT

Brief summary: Patients with plantar fasciitis between the ages of 25-65 years who presented to the Physical Medicine and Rehabilitation clinic with the complaint of heel pain and met the inclusion and exclusion criteria will be included in the study. Demographic data (age, gender, body mass index, symptom duration) will be recorded at the beginning of the study. Then, Foot Functional Index (FFI) and Visual Analog Scale (VAS) scales will be recorded. Participants will be randomly divided into two groups. Group 1 will receive dry needling and Group 2 will receive extracorporeal shock wave therapy (ESWT). Patients in the 1st group will undergo 3 sessions of dry needling with Seirin branded 0.6\*50 mm acupuncture needles at one week intervals for the trigger point detected by manual palpation in the medial gastrocnemius, lateral gastrocnemius, soleus, flexor digitorum brevis, quadratus plantae, abductor hallucis brevis muscles. Patients in the 2nd group, Patients in this group received three sessions of ESWT (MASTERPLUS MP 200 ENERGY 2 trademarked ESWT device) at an energy density of 2 bars and a frequency of 2,000 shocks/min at 12 Hz for three weeks, each session once a week. Each of the five most sensitive and painful points was given 400 pulses in the supine position


Eligibility criteria: Inclusion Criteria:

* Patients aged 25-65 years with heel pain for more than 6 weeks
* tenderness on palpation in the medial calcaneal region
* aggravation of symptoms while standing and in the first hours of the morning
* who agreed not to receive anti-inflammatory treatment during the study period
* fascia thickness \>4mm measured by ultrasound.

Exclusion Criteria:

* Patients diagnosed with rheumatologic diseases
* Those diagnosed with Diabetes Mellitus (DM), those with chronic liver and kidney failure
* Anti-inflammatory-analgesic treatment within the last 1 month
* Diagnosed with inflammatory rheumatic disease
* Those with a history of foot surgery
* Those with mid or hindfoot deformity
* Previous history of central or peripheral nerve damage, lower extremity neuropathy
* Those diagnosed with Diabetes Mellitus
* Those with cognitive impairment
* Unassisted mobilization
* Those with bleeding disorders
* Pregnant women

Primary outcomes:
measure: Pain was evaluated with a Visual analog scale (VAS) score.
timeFrame: 5 months
measure: Function was evaluated with (Foot Functional Index) FFI score.
timeFrame: 5 months
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul Training and Resarch Hospital
Study officials:
affiliation: İstanbul Training and Research Hospital
name: Burak Tayyip Dede
role: PRINCIPAL_INVESTIGATOR
References: